Chronic Levodopa Administration Followed by a Washout Period Increased Number and Induced Phenotypic Changes in Striatal Dopaminergic Cells in MPTP-Monkeys

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  DiCaudo, Carla ^a   Riverol, Mario ^a   Mundiñano, Iñaki Carril ^a   Ordoñez, Cristina ^a   Hernández, María ^a   Marcilla, Irene ^a   Luquin, Maria Rosario ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; CALRETININ; DOPAMINE; GLUTAMATE DECARBOXYLASE 67; LEVODOPA; PHOSPHOPROTEIN DARPP 32;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DENSITY; CELLULAR DISTRIBUTION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DYSKINESIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MACACA FASCICULARIS; MALE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEHAVIOR, ANIMAL; DOPAMINERGIC NEURONS; FLUORESCENT ANTIBODY TECHNIQUE; LEVODOPA; MACACA FASCICULARIS; MALE; NEOSTRIATUM; PHENOTYPE; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MACACA; MACACA FASCICULARIS; MAMMALIA;

EID: 84870666485     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050842     Document Type: Article

References (41)

1. Graveland GA, DiFiglia M, (1985) The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum. Brain Res 327: 307-11.
2. DiFiglia M, Pasik P, Pasik T, (1976) A golgi study of neuronal types in the neostriatum of monkeys. Brain Res 114: 245-56.
3. Bishop GA, Chang HT, Kitai ST, (1982) Morphological and physiological properties of neostriatal neurons: An intracellular horseradish peroxidase study in the rat. Neuroscience 7: 179-91.
4. Tashiro Y, Sugimoto T, Hattori T, Uemura Y, Nagatsu I, et al. (1989) Tyrosine hydroxylase-like immunoreactive neurons in the striatum of the rat. Neurosci Lett 97: 6-10.
5. Mura A, Jackson D, Manley MS, Young SJ, Groves PM, (1995) Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: A possible site for the conversion of exogenous L-DOPA to dopamine. Brain Res 704: 51-60.
6. Meredith GE, Farrell T, Kellaghan P, Tan Y, Zahm DS, et al. (1999) Immunocytochemical characterization of catecholaminergic neurons in the rat striatum following dopamine-depleting lesions. Eur J Neurosci 11: 3585-96.
7. Dubach M, Schmidt R, Kunkel D, Bowden DM, Martin R, et al. (1987) Primate neostriatal neurons containing tyrosine hydroxylase: Immunohistochemical evidence. Neurosci Lett 75: 205-10.
8. Betarbet R, Turner R, Chockkan V, DeLong MR, Allers KA, et al. (1997) Dopaminergic neurons intrinsic to the primate striatum. J Neurosci 17: 6761-8.
9. Mazloom M, Smith Y, (2006) Synaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys. J Comp Neurol 495: 453-69.
10. Tande D, Hoglinger G, Debeir T, Freundlieb N, Hirsch EC, et al. (2006) New striatal dopamine neurons in MPTP-treated macaques result from a phenotypic shift and not neurogenesis. Brain 129: 1194-200.
11. Huot P, Levesque M, Parent A, (2007) The fate of striatal dopaminergic neurons in parkinson's disease and huntington's chorea. Brain 130: 222-32.
12. Porritt MJ, Batchelor PE, Hughes AJ, Kalnins R, Donnan GA, et al. (2000) New dopaminergic neurons in parkinson's disease striatum. Lancet 356: 44-5.
13. Cossette M, Lecomte F, Parent A, (2005) Morphology and distribution of dopaminergic neurons intrinsic to the human striatum. J Chem Neuroanat 29: 1-11.
14. Cossette M, Parent A, Levesque D, (2004) Tyrosine hydroxylase-positive neurons intrinsic to the human striatum express the transcription factor Nurr1. The European Journal of Neuroscience 20: 2089-2095.
15. Ibanez-Sandoval O, Tecuapetla F, Unal B, Shah F, Koos T, et al. (2010) Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum. J Neurosci 30: 6999-7016.
16. Bezard E, Gross CE, (1998) Compensatory mechanisms in experimental and human parkinsonism: Towards a dynamic approach. Prog Neurobiol 55: 93-116.
17. Huot P, Levesque M, Morissette M, Calon F, Dridi M, et al. (2008) L-dopa treatment abolishes the numerical increase in striatal dopaminergic neurons in parkinsonian monkeys. J Chem Neuroanat 35: 77-84.
18. Cicchetti F, Prensa L, Wu Y, Parent A, (2000) Chemical anatomy of striatal interneurons in normal individuals and in patients with huntington's disease. Brain Research.Brain Research Reviews 34: 80-101.
19. Luquin MR, Montoro RJ, Guillen J, Saldise L, Insausti R, et al. (1999) Recovery of chronic parkinsonian monkeys by autotransplants of carotid body cell aggregates into putamen. Neuron 22: 743-50.
20. Martin RF, Bowden DM, (1996) A stereotaxic template atlas of the macaque brain for digital imaging and quantitative neuroanatomy. Neuroimage 4: 119-50.
21. San Sebastian W, Guillen J, Manrique M, Belzunegui S, Ciordia E, et al. (2007) Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft. Brain 130: 1306-16.
22. Bink K, Walch A, Feuchtinger A, Eisenmann H, Hutzler P, et al. (2001) TO-PRO-3 is an optimal fluorescent dye for nuclear counterstaining in dual-colour FISH on paraffin sections. Histochemistry and Cell Biology 115: 293-299.
23. Ouimet CC, Greengard P, (1990) Distribution of DARPP-32 in the basal ganglia: An electron microscopic study. Journal of Neurocytology 19: 39-52.
24. Palfi S, Leventhal L, Chu Y, Ma SY, Emborg M, et al. (2002) Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 22: 4942-4954.
25. Brotchie J, Fitzer-Attas C, (2009) Mechanisms compensating for dopamine loss in early parkinson disease. Neurology 72: S32-8.
26. Riverol M, Ordonez C, Marcilla I, DiCaudo C, Hernandez B, et al. (2011) Effect of MPTP and chronic levodopa treatment on striatal dopaminergic markers. Movement Disorders: Official Journal of the Movement Disorder Society 26: S25.
27. O'Sullivan SS, Johnson M, Williams DR, Revesz T, Holton JL, et al. (2011) The effect of drug treatment on neurogenesis in parkinson's disease. Movement Disorders: Official Journal of the Movement Disorder Society 26: 45-50.
28. Jollivet C, Montero-Menei CN, Venier-Julienne MC, Sapin A, Benoit JP, et al. (2004) Striatal tyrosine hydroxylase immunoreactive neurons are induced by L-dihydroxyphenylalanine and nerve growth factor treatment in 6-hydroxydopamine lesioned rats. Neurosci Lett 362: 79-82.
29. Luquin MR, Manrique M, Guillen J, Arbizu J, Ordonez C, et al. (2011) Enhanced GDNF expression in dopaminergic cells of monkeys grafted with carotid body cell aggregates. Brain Res 1375: 120-7.
30. Bartus RT, Herzog CD, Chu Y, Wilson A, Brown L, et al. (2011) Bioactivity of AAV2-neurturin gene therapy (CERE-120): Differences between parkinson's disease and nonhuman primate brains. Movement Disorders: Official Journal of the Movement Disorder Society 26: 27-36.
31. Hou JG, Lin LF, Mytilineou C, (1996) Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. Journal of Neurochemistry 66: 74-82.
32. Bjugstad KB, Redmond DE, Teng YD, Elsworth JD, Roth RH, et al. (2005) Neural stem cells implanted into MPTP-treated monkeys increase the size of endogenous tyrosine hydroxylase-positive cells found in the striatum: A return to control measures. Cell Transplantation 14: 183-192.
33. Okazawa H, Murata M, Watanabe M, Kamei M, Kanazawa I, (1992) Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum. FEBS Letters 313: 138-142.
34. Kay JN, Blum M, (2000) Differential response of ventral midbrain and striatal progenitor cells to lesions of the nigrostriatal dopaminergic projection. Developmental Neuroscience 22: 56-67.
35. Luzzati F, De Marchis S, Parlato R, Gribaudo S, Schutz G, et al. (2011) New striatal neurons in a mouse model of progressive striatal degeneration are generated in both the subventricular zone and the striatal parenchyma. PloS One 6: e25088.
36. Haber SN, (2003) The primate basal ganglia: Parallel and integrative networks. J Chem Neuroanat 26: 317-30.
37. Bernacer J, Prensa L, Gimenez-Amaya JM, (2012) Distribution of GABAergic interneurons and dopaminergic cells in the functional territories of the human striatum. PloS One 7: e30504.
38. Calabresi P, Di Filippo M, Ghiglieri V, Picconi B, (2008) Molecular mechanisms underlying levodopa-induced dyskinesia. Mov Disord 23Suppl 3: S570-9.
39. Belujon P, Lodge DJ, Grace AA, (2010) Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment. Movement Disorders: Official Journal of the Movement Disorder Society 25: 1568-1576.
40. Weihe E, Depboylu C, Schutz B, Schafer MK, Eiden LE, (2006) Three types of tyrosine hydroxylase-positive CNS neurons distinguished by dopa decarboxylase and VMAT2 co-expression. Cell Mol Neurobiol 26: 659-78.
41. Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, et al. (2011) Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of parkinson's disease. Neurobiol Dis.